IL132389A0 - Method and composition for treating chronic progressive vascular scarring diseases - Google Patents

Method and composition for treating chronic progressive vascular scarring diseases

Info

Publication number
IL132389A0
IL132389A0 IL13238998A IL13238998A IL132389A0 IL 132389 A0 IL132389 A0 IL 132389A0 IL 13238998 A IL13238998 A IL 13238998A IL 13238998 A IL13238998 A IL 13238998A IL 132389 A0 IL132389 A0 IL 132389A0
Authority
IL
Israel
Prior art keywords
composition
treating chronic
chronic progressive
progressive vascular
vascular scarring
Prior art date
Application number
IL13238998A
Other languages
English (en)
Original Assignee
Us Health
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25283204&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL132389(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Us Health filed Critical Us Health
Publication of IL132389A0 publication Critical patent/IL132389A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Dermatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL13238998A 1997-04-16 1998-04-10 Method and composition for treating chronic progressive vascular scarring diseases IL132389A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/840,777 US20010005720A1 (en) 1995-06-07 1997-04-16 Method of treating chronic progressive vascular scarring diseases
PCT/US1998/007517 WO1998046237A1 (en) 1997-04-16 1998-04-10 Method of treating chronic progressive vascular scarring diseases

Publications (1)

Publication Number Publication Date
IL132389A0 true IL132389A0 (en) 2001-03-19

Family

ID=25283204

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13238998A IL132389A0 (en) 1997-04-16 1998-04-10 Method and composition for treating chronic progressive vascular scarring diseases

Country Status (17)

Country Link
US (1) US20010005720A1 (ko)
EP (1) EP0986392A4 (ko)
JP (1) JPH1149802A (ko)
KR (1) KR20010006511A (ko)
CN (1) CN1259871A (ko)
AR (1) AR008559A1 (ko)
AU (1) AU750182B2 (ko)
BR (1) BR9809396A (ko)
CA (1) CA2285950A1 (ko)
HU (1) HUP0003256A3 (ko)
IL (1) IL132389A0 (ko)
NO (1) NO995024L (ko)
NZ (1) NZ500527A (ko)
SK (1) SK142599A3 (ko)
TW (1) TW557213B (ko)
WO (1) WO1998046237A1 (ko)
ZA (1) ZA982246B (ko)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2583079A1 (en) * 2004-10-01 2006-04-13 Keryx Biopharmaceuticals, Inc. Methods using glycosaminoglycans for the treatment of kidney disease
US9339524B2 (en) 2009-03-11 2016-05-17 Jellice Co., Ltd. Drug inhibiting the progression of atherosclerosis, preventive drug, blood cholesterol-lowering drug, functional food, and specific health food
CN102327282A (zh) * 2010-09-01 2012-01-25 吴洪 戊糖多聚硫酸酯用于制备治疗糖尿病肾病的药物中的用途
AU2017321817B2 (en) 2016-08-31 2022-12-15 Oji Holdings Corporation Production method for acidic xylooligosaccharide, and acidic xylooligosaccharide
JP6225321B1 (ja) 2016-08-31 2017-11-08 王子ホールディングス株式会社 ポリ硫酸ペントサンの製造方法
JP6281659B1 (ja) 2017-02-28 2018-02-21 王子ホールディングス株式会社 ポリ硫酸ペントサン、医薬組成物及び抗凝固剤
SG11201911318SA (en) 2017-05-31 2020-01-30 Oji Holdings Corp Moisturizing topical preparation
WO2019054344A1 (ja) 2017-09-12 2019-03-21 王子ホールディングス株式会社 ポリ硫酸ペントサン及びポリ硫酸ペントサンの製造方法
CN111511773B (zh) 2017-12-20 2023-01-13 王子控股株式会社 戊聚糖多硫酸酯以及含有戊聚糖多硫酸酯的药物
WO2023070164A1 (en) * 2021-10-28 2023-05-04 Paradigm Biopharmaceuticals Ltd Treatment of heart failure with preserved ejection fraction

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4820693A (en) * 1986-05-22 1989-04-11 Angiogenics, Ltd. Method and composition for arresting angiogenesis and capillary, cell or membrane leakage
US5643892A (en) * 1995-06-07 1997-07-01 Baker Norton Pharmaceuticals, Inc. Method of treating chronic progressive vascular diseases

Also Published As

Publication number Publication date
HUP0003256A2 (hu) 2001-02-28
WO1998046237A1 (en) 1998-10-22
EP0986392A4 (en) 2000-04-26
HUP0003256A3 (en) 2001-12-28
EP0986392A1 (en) 2000-03-22
TW557213B (en) 2003-10-11
NO995024D0 (no) 1999-10-15
JPH1149802A (ja) 1999-02-23
US20010005720A1 (en) 2001-06-28
KR20010006511A (ko) 2001-01-26
AU7248298A (en) 1998-11-11
AR008559A1 (es) 2000-01-19
ZA982246B (en) 1998-09-17
CA2285950A1 (en) 1998-10-22
CN1259871A (zh) 2000-07-12
NO995024L (no) 1999-12-13
NZ500527A (en) 2001-10-26
AU750182B2 (en) 2002-07-11
BR9809396A (pt) 2000-06-13
SK142599A3 (en) 2001-12-03

Similar Documents

Publication Publication Date Title
HUP0001237A3 (en) Methods for treating vascular disorders
EP1022945A4 (en) METHOD AND FORMULATION FOR THE TREATMENT OF VASCULAR DISEASES
AU5911798A (en) Apparatus and method for treating chronic constipation
GR3036364T3 (en) Compositions and methods for treating or preventing inflammatory diseases
AU9035498A (en) Method for treating pain
EP0866683A4 (en) MEANS AND METHOD FOR TREATING DISEASE NAILS
HK1031174A1 (en) Compositions and methods for treating diabetes
IL133078A0 (en) Method of treating nitrate-induced tolerance
IL132758A0 (en) Methods for treating inflammation and inflammatory diseases using padprt
IL126759A0 (en) Method for treating inflammation
IL132389A0 (en) Method and composition for treating chronic progressive vascular scarring diseases
EP1007046A4 (en) METHOD FOR TREATING CHRONIC BRONCHITIS
AU6151899A (en) Methods of treating chronic pain
ZA964247B (en) Method of treating chronic progressive vascular diseases
IL126744A0 (en) Method of inhibiting vascular cell adhesion molecule-1 and treating chronic inflammatory diseases with 2,6-Di-alkyl-4-silyl-phenols
IL124650A0 (en) Methods and therapeutic compositions for treating cancer
PL336771A1 (en) Method of treating mental diseases among mammals and composition therefor
EP1089731A4 (en) COMPOSITIONS AND METHOD FOR TREATING INCREASED BLOOD CHOLESTEROL LEVELS
AU9034798A (en) Method for treating pain
GB9714841D0 (en) Treatment method
AU5173998A (en) Therapeutic methods for vascular injury
EP1007041A4 (en) COMPOSITION FOR TREATING PAIN
ZA971899B (en) Method for treating insomnia
EP1089732A4 (en) COMPOSITIONS AND METHODS FOR TREATING INCREASED BLOOD CHOLESTEROL LEVELS
AU4914600A (en) Method for treating tnf-receptor type-2-induced diseases